rs1554285766
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP5_Moderate
The NM_000426.4(LAMA2):c.5071+3104delC variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Consequence
NM_000426.4 intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LAMA2 | ENST00000421865.3 | c.5071+3104delC | intron_variant | Intron 35 of 64 | 5 | NM_000426.4 | ENSP00000400365.2 | |||
LAMA2 | ENST00000618192.5 | c.5335+3104delC | intron_variant | Intron 36 of 65 | 5 | ENSP00000480802.2 | ||||
LAMA2 | ENST00000617695.5 | c.5071+3104delC | intron_variant | Intron 35 of 63 | 5 | ENSP00000481744.2 | ||||
LAMA2 | ENST00000687590.1 | n.1491+3104delC | intron_variant | Intron 3 of 4 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
LAMA2-related muscular dystrophy Pathogenic:1
This sequence change deletes 82 nucleotides from exon 36 of the LAMA2 mRNA (c.5072-5154del), causing a frameshift at codon 1691. This creates a premature translational stop signal (p.Ala1691Glufs*4) and is expected to result in an absent or disrupted protein product. While this particular variant has not been reported in the literature, truncating variants in LAMA2 are known to be pathogenic (PMID: 18700894). For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at